Akèy › Lukemi lenfositè kwonik › Missouri › O'Fallon

Etid klinik pou Lukemi lenfositè kwonik nan O'Fallon, MO

4 etid pou Lukemi lenfositè kwonik ap chèche patisipan nan sit nan ak bò kote O'Fallon (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Ap rekriteFaz 3

Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters · 4 mi lwen

Laj 65 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07321652

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi

Saint Luke's Hospital, Chesterfield · 12 mi lwen
Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin · 17 mi lwen
Mercy Hospital Washington, Washington · 24 mi lwen

Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Ap rekriteFaz 3

Saint Luke's Hospital, Chesterfield · 12 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT04269902

A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

Ap rekriteFaz 3

St Lukes Center For Cancer Care, Chesterfield · 12 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06846671

Etid Lukemi lenfositè kwonik nan lòt vil

Lòt etid nan O'Fallon

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.